Davis's Drug Guide
datopotamab deruxtecan
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
da-toe-poe-tah-mab der-ux-tee-kan
Trade Name(s)
- Datroway
Ther. Class.
Pharm. Class.
monoclonal antibodies
enzyme inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Datopotamab Deruxtecan." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580129/all/datopotamab_deruxtecan.
Vallerand AHA, Sanoski CAC, . Datopotamab deruxtecan. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580129/all/datopotamab_deruxtecan. Accessed October 16, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Datopotamab deruxtecan. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580129/all/datopotamab_deruxtecan
Vallerand AHA, Sanoski CAC, . Datopotamab Deruxtecan [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 16]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580129/all/datopotamab_deruxtecan.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - datopotamab deruxtecan
ID - 3580129
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580129/all/datopotamab_deruxtecan
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
